Sertraline treatment influences [ 18 F]FE-PE2I PET imaging for Parkinsonism.
Thomas E H JustesenPer BorghammerJoel AanerudPeter HovindLisbeth MarnerPublished in: EJNMMI research (2023)
F]FE-PE2I PET especially in patients showing apparent globally reduced PE2I binding. If tolerable, pausing of the sertraline treatment should be considered, especially for doses above 50 mg/day.